Thursday, April 16, 2026 – THURSDAY, April 16, 2026 -- Social media posts about glucagon-like peptide-1 receptor agonists may identify patient concerns not captured in clinical trials, according to a study published online April 10 in Nature Health.Neil K.R. Sehgal, from the...
Thursday, April 16, 2026 – Friday, April 17 - Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't actually necessary to achieve effective weight loss.
Thursday, April 16, 2026 – Friday, April 17 - As more people turn to prescription drugs for smaller weight-loss goals, one writer explores the pros and cons.
Thursday, April 16, 2026 – Friday, April 17 - A recent poll found 1 in 8 adults take a GLP-1 medication like Ozempic or Wegovy and 27 percent of those users said even though they have insurance, they still pay out-of-pocket for those drugs. NBC News medical contributor Dr. Natalie Azar and chief business correspondent Christine Romans join TODAY to break down the different weight loss drugs, how to know if your insurance will cover them and more.
Wednesday, April 15, 2026 – Thursday, April 16 - Insurance coverage of blockbuster obesity drugs has been spotty at best over the years, and it looks like things are getting worse, not better. Plans are dropping coverage or restricting it further.
Wednesday, April 15, 2026 – Thursday, April 16 - If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a commercial.
Wednesday, April 15, 2026 – Thursday, April 16 - Over the past few years, GLP-1 receptor agonists have been growing in popularity for weight loss.
While many people lose between 5-15% of their starting body weight while on a GLP-1, as much as 20% of people may not respond to the drug.
Recent research has found that a person’s genetic makeup may explain why some people do not respond to GLP-1 drugs.
A new review suggests that taking both a GLP-1 medication, and a medication that combines both naltrexone and bupropion into one pill, may be helpful for those who are not responding to GLP-1s alone.
Wednesday, April 15, 2026 – Wednesday, April 15 - A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again. Research hasn't yet shown the health impacts of cycling on and off the drugs.
Tuesday, April 14, 2026 – Wednesday, April 15 - (MedPage Today) -- Eating the same meals every day may aid in weight loss, according to a study of real-time food tracking data. (Health Psychology)
The prevalence of youth-onset type 2 diabetes increased substantially from 2013 to 2024, rising...
Tuesday, April 14, 2026 – Wednesday, April 15 - Research has found that the effectiveness of GLP-1 drugs may vary based on a person’s genetics. Image Credit: Indranil MUKHERJEE / AFP via Getty Images
GLP-1 medications may not always be effective for everyone.
New research suggests that around 10% of people carry genetic variations that explain why.